drugset / Trial / NCT00469521

Pilot Study Evaluation of 2 Artificial Tears. Evaluation of TBUT, Tear Meniscus Height and Tear Thickness

NCT00469521

Phase 4 Completed Innovative Medical
Non-randomizedParallel-groupOpen-label

Summary

To determine baseline tear thickness and improvement immediately post installation of two artificial tear solutions:(9582X) and Allergan Refresh Tears.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject 9582X Unknown
Subject Refresh Tears Unknown

Indications

No indication recorded.